Category:

EMNUK Ltd proposes plans to restructure
EMNUK Ltd (“EMNUK”), an Essilor Group company, has today proposed plans to restructure its site in Quedgeley, Gloucester, and withdraw the Kodak brand
Read More..
Iridex Announces Strategic Collaboration With Topcon
Iridex announced that it has entered into a strategic collaboration with Topcon.
Read More..
NHS ENGLAND Rejects Support Proposal for struggling practices
Many in the sector had responded to our call for evidence on the impact of the new lockdown, demonstrating that targeted support was needed. We proposed a targeted safety net scheme to support practices which had seen a fall of 50% or more in GOS activity.
Read More..
The effect of a pandemic on glaucoma detection rates.A story fit for World Glaucoma Week
Specsavers data is helping to demonstrate the impact of the Covid-19 pandemic on glaucoma care, in the lead up to World Glaucoma Week (7-13 March).
Read More..
New partnership focussed on improving eye health services for Gloucestershire
Newmedica has taken on its first trainee nurse as part of a partnership with the University of Gloucestershire to train tomorrow’s top ophthalmology nurses.
Read More..
Eyecare advice is provided as children go back to school
Parents are concerned about their child’s time spent on screens but view new shoes as ‘more important’ than eye tests for back to school.
Read More..
The College of Optometrists’ Optometry Tomorrow Bitesize to take place as month-long online learning event
The College of Optometrists is running Optometry Tomorrow Bitesize as a month-long online learning event for members, starting from Tuesday 2 March.
Read More..
Clinical Hub launched for ABDO members
The Association of British Dispensing Opticians (ABDO) has launched a clinical hub for members which will bring together up to date research and current knowledge on a range of topics
Read More..
AIO Conference to go ahead on 9th and 10th October
AIO has announced that its Annual Conference will take place at Chesford Grange in Warwickshire on 9th and 10th October 2021.
Read More..
Allergan Submits New Drug Application for Investigational Eye Drop for the Treatment of Presbyopia
Allergan announced that it has submitted a new drug application to the FDA for investigational AGN-190584 (pilocarpine 1.25%) ophthalmic solution for the treatment of presbyopia.
Read More..





















